Versigent (VGNT) – Investment Analysts’ Recent Ratings Changes

Versigent (NYSE: VGNT) has recently received a number of price target changes and ratings updates:

• 7/21/2026 – Versigent was given a new $50.00 price target by Argus.
• 7/21/2026 – Versigent was given a new $50.00 price target by Oppenheimer Holdings, Inc..
• 7/21/2026 – Versigent was upgraded by Argus to “strong-buy”.
• 7/20/2026 – Versigent is now covered by The Goldman Sachs Group, Inc.. They set a “buy” rating and a $48.00 price target on the stock.
• 7/20/2026 – Versigent is now covered by The Goldman Sachs Group, Inc.. They set a “buy” rating and a $48.00 price target on the stock.
• 7/13/2026 – Versigent had its price target raised by Royal Bank Of Canada from $34.00 to $41.00. They now have a “sector perform” rating on the stock.
• 7/9/2026 – Versigent had its price target lowered by UBS Group AG from $58.00 to $55.00. They now have a “buy” rating on the stock.
• 7/7/2026 – Versigent was upgraded by Deutsche Bank Aktiengesellschaft from “hold” to “buy”. They now have a $50.00 price target on the stock.
• 7/2/2026 – Versigent was upgraded by Zacks Research from “hold” to “strong-buy”.
• 6/25/2026 – Versigent had its price target raised by Wells Fargo & Company from $42.00 to $48.00. They now have an “overweight” rating on the stock.
• 6/5/2026 – Versigent had its price target raised by UBS Group AG from $49.00 to $58.00. They now have a “buy” rating on the stock.